Park Square is pleased to announce the placement of Mark Williams as Corporate Controller at Affinaquest. Williams most recently served...
Park Square is pleased to announce the placement of Ozge Whiting, Ph.D. as Vice President, Data and Machine Learning at Cellino Biotech....
23andMe Holding Co. (Nasdaq: ME), a leading consumer genetics and therapeutics company, today announced the appointment of Joseph R....
Park Square has placed Edward "Tad" Stewart as Chief Business Officer at GRO Biosciences, an emerging biotechnology company leveraging...
Park Square is pleased to announce the placement of Katya Taycher as Vice President, Head of Product at Verity, a leading provider of...
Park Square is pleased to announce the placement of Camella Wilson, Ph.D., as Senior Associate at Northpond Ventures. Northpond builds...
Park Square has placed Thomas Patterson, Jr. as Chief Executive Officer at EnergyCAP.
Park Square is pleased to announce the appointment of Qin Yu, Ph.D., to the position of Vice President, Discovery at Carmine...
Park Square has placed Gary Hall as Chief Financial Officer at 6K.
Park Square has placed William Hodder as Chief Executive Officer at NFlection Therapeutics, Inc.
Park Square is pleased to announce the appointment of Eric Gomez, Ph.D., to the position of Principal, Investments at Mubadala Capital....
Park Square is pleased to announce the placement of Dr. Robert Gould as an Independent Director at Faeth Therapeutics. Faeth is a...
Park Square is pleased to announce the appointment of Juan Avendano to the position of Vice President, Head of Investor Relations at...